What is the appropriate management for a 72-year-old man with chronic depression who is taking bupropion (Wellbutrin) 450 mg daily without improvement?

Management of Treatment-Resistant Depression in a 72-Year-Old on Maximum-Dose Bupropion

You should modify treatment immediately, as this patient has failed adequate therapy with bupropion 450 mg daily (the maximum dose), and guideline-based evidence strongly recommends changing treatment strategy after 6-8 weeks of inadequate response. 1

Treatment Modification Strategy

The American College of Physicians provides clear guidance: when patients fail to respond adequately to pharmacotherapy within 6-8 weeks, clinicians must modify treatment 1. Since this patient is on maximum-dose bupropion without improvement, you have three evidence-based options:

Option 1: Switch to a Different Second-Generation Antidepressant (Preferred for Elderly)

Switch to an SSRI or SNRI specifically recommended for older adults:

• Preferred agents for this 72-year-old patient: citalopram, escitalopram, sertraline, mirtazapine, or venlafaxine 2
• Avoid: paroxetine and fluoxetine due to higher adverse effect rates in older adults 2

Rationale: Moderate-quality evidence shows no significant difference in efficacy when switching between second-generation antidepressants (bupropion vs. sertraline vs. venlafaxine) 3. However, the choice should prioritize safety profile in this elderly patient. Citalopram or escitalopram would be excellent first choices given their tolerability and lower drug interaction potential in older adults.

Option 2: Augment Current Bupropion

Add a second antidepressant to the existing bupropion:

• Evidence-based augmentation: Add an SSRI (particularly citalopram or sertraline) to continue bupropion 3
• Low-quality evidence shows augmenting citalopram with bupropion reduces depression severity more than augmentation with buspirone 3
• This strategy has been used successfully in treatment-resistant depression, combining different mechanisms (dopamine/norepinephrine with serotonin) 4

Important consideration: The combination of bupropion with SSRIs is generally safe, though monitor for serotonin syndrome and be aware that bupropion inhibits CYP2D6, potentially increasing SSRI levels 5

Option 3: Switch to Cognitive Behavioral Therapy or Combination Therapy

Low-quality evidence shows no difference between switching to another antidepressant versus switching to cognitive therapy 3. Consider adding CBT to any pharmacologic strategy, as combination therapy may be superior to monotherapy.

Critical Safety Considerations for This 72-Year-Old

Blood Pressure Monitoring

• Bupropion can cause hypertension, particularly at 450 mg daily 5
• Before continuing or switching, check blood pressure regularly
• If hypertension develops, this becomes another reason to switch agents

Cardiovascular Assessment

• The FDA label notes lack of controlled studies in patients with recent MI or unstable cardiac disease 5
• In elderly patients with stable CHF, bupropion has caused hypertension exacerbation 5
• Obtain cardiovascular history before proceeding

Seizure Risk

• At 450 mg daily, seizure risk is approximately 1 in 1000 6, 5
• This is the maximum recommended dose; do not exceed it
• Review for other seizure risk factors

Suicide Risk Assessment

• Critical: Monitor closely for suicidal ideation, especially during treatment transitions 1
• SSRIs carry increased risk for nonfatal suicide attempts compared to placebo 1
• Begin monitoring within 1-2 weeks of any medication change 1

Specific Dosing Algorithm for Switching

If switching to citalopram (recommended for this patient):

1. Start citalopram 10 mg daily (elderly dose) 7
2. Can taper bupropion over 1-2 weeks while initiating citalopram
3. Titrate citalopram to 20-40 mg daily as tolerated (maximum 40 mg in elderly) 7
4. Reassess response at 6-8 weeks

If switching to sertraline:

1. Start sertraline 25-50 mg daily 7
2. Titrate to 100-200 mg daily as needed
3. Better tolerated with fewer drug interactions than other SSRIs 7

If switching to mirtazapine (particularly if insomnia or poor appetite):

1. Start 7.5 mg at bedtime 7
2. Titrate to 15-30 mg at bedtime
3. Promotes sleep, appetite, and weight gain—useful if these are issues 7

Duration of Treatment

• First episode of major depression requires at least 4 months of treatment after achieving remission 2
• For chronic/recurrent depression (which this patient likely has given treatment resistance), consider prolonged or indefinite treatment 2

Common Pitfalls to Avoid

1. Don't wait indefinitely: The evidence is clear that 6-8 weeks is adequate to determine response 1
2. Don't underdose the new agent: Ensure adequate dosing and duration before declaring another failure
3. Don't ignore combination therapy: Nearly 50% of elderly depressed patients may need combination therapy 8
4. Don't forget non-pharmacologic options: Consider adding psychotherapy regardless of medication strategy

The bottom line: This patient needs a treatment change now. Switching to citalopram or escitalopram (10-20 mg daily) or augmenting with one of these agents represents the most evidence-based approach for a 72-year-old with treatment-resistant depression, balancing efficacy with the superior safety profile needed in elderly patients.